SHARE AND WARRANT PURCHASE
AGREEMENT
THIS SHARE AND
WARRANT PURCHASE AGREEMENT (“Agreement”) is made as of
the 23rd day of April, 2007, by and among Golden Phoenix Minerals,
Inc., a Minnesota corporation (the “Company”), and each
investor set forth on the signature pages affixed hereto (each,
including its successors and assigns, an “Investor” and
collectively the “Investors”).
A. The
Company and the Investors are executing and delivering this
Agreement in reliance upon the exemption from securities
registration afforded by Rule 506 of Regulation D
(“Regulation D”), as promulgated by the U.S.
Securities and Exchange Commission (the “SEC”) under
the Securities Act of 1933, as amended; and
B. The
Investors wish to purchase from the Company, and the Company wishes
to sell and issue to the Investors, upon the terms and conditions
stated in this Agreement, an aggregate of twenty million
(20,000,000) units (the “Units”) of the Company at a
purchase price of $0.30 per Unit. Each Unit consists of a share of
the Company’s common stock, no par value per share (together
with any securities into which such shares may be reclassified the
“Common Stock”), and one-half (1/2) of one warrant to
purchase Common Stock, with each whole warrant entitling the holder
to purchase one share of Common Stock at an exercise price of no
less than $0.40 per share and no more than $0.45 per share with the
price set between the minimum and maximum at $0.03 per share above
the closing price for a share of the Company’s Common Stock
the day immediately preceding the execution of this Agreement by
the first Investor in the form attached hereto as Exhibit A
(the “Warrants”); and
C. Contemporaneous
with the sale of the Common Stock and Warrants, the parties hereto
will execute and deliver a Registration Rights Agreement, in the
form attached hereto as Exhibit B (the “Registration
Rights Agreement”), pursuant to which the Company will agree
to provide certain registration rights under the 1933 Act, and the
rules and regulations promulgated thereunder, and applicable state
securities laws.
In consideration
of the mutual promises made herein and for other good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:
1.
Definitions . In addition to those terms defined above and
elsewhere in this Agreement, for the purposes of this Agreement,
the following terms shall have the meanings set forth
below:
“
Accredited Investor ” means an “accredited
investor” as such term is defined in Rule 501(a) of
Regulation D.
“
Affiliate ” means, with respect to any Person, any
other Person which directly or indirectly through one or more
intermediaries controls, is controlled by, or is under
common
1
control with,
such Person as such terms are used in and construed under
Rule 405 under the Securities Act. With respect to an
Investor, any investment fund or managed account that is managed on
a discretionary basis by the same investment manager as such
Investor will be deemed to be an Affiliate of such
Investor.
“
Business Day ” means a day, other than a Saturday or
Sunday, and any day which is a federal legal holiday in the United
States or any day on which banking institutions in the State of New
York are authorized or required by law or other governmental action
to close.
“
Company’s Knowledge ” means the actual knowledge
of the executive officers (as defined in Rule 405 under the
1933 Act) of the Company.
“
Confidential Information ” means trade secrets,
confidential information and know-how (including but not limited to
ideas, formulae, compositions, processes, procedures and
techniques, research and development information, computer program
code, performance specifications, support documentation, drawings,
specifications, designs, business and marketing plans, and customer
and supplier lists and related information).
“
Control ” (including the terms
“controlling”, “controlled by” or
“under common control with”) means the possession,
direct or indirect, of the power to direct or cause the direction
of the management and policies of a Person, whether through the
ownership of voting securities, by contract or
otherwise.
“
Effective Date ” means the date on which the initial
Registration Statement is first declared effective by the
SEC.
“
Effectiveness Deadline ” means the date on which the
initial Registration Statement is required to be declared effective
by the SEC under the terms of the Registration Rights
Agreement.
“
Intellectual Property ” means all of the following:
(i) patents, patent applications, patent disclosures and
inventions (whether or not patentable and whether or not reduced to
practice); (ii) trademarks, service marks, trade dress, trade
names, corporate names, logos, slogans and Internet domain names,
together with all goodwill associated with each of the foregoing;
(iii) copyrights and copyrightable works;
(iv) registrations, applications and renewals for any of the
foregoing; and (v) proprietary computer software (including
but not limited to data, data bases and documentation).
“
Material Adverse Effect ” means a material adverse
effect on (i) the assets, liabilities, results of operations,
condition (financial or otherwise), business, or prospects of the
Company and its Subsidiaries taken as a whole, or (ii) the
ability of the Company to perform its obligations under the
Transaction Documents.
“
Person ” means an individual, corporation,
partnership, limited liability company, trust, business trust,
association, joint stock company, joint venture, sole
proprietorship,
2
unincorporated
organization, governmental authority or any other form of entity
not specifically listed herein.
“
Purchase Price ” means Six Million Dollars
($6,000,000.00).
“
SEC Filings ” has the meaning set forth in
Section 4.6.
“
Registration Statement ” has the meaning set forth in
the Registration Rights Agreement.
“
Securities ” means the Shares, the Warrants and the
Warrant Shares.
“
Shares ” means the shares of Common Stock being
purchased by the Investors hereunder.
“
Subsidiary ” of any Person means another Person owning
directly or indirectly, an amount of the voting securities, other
voting ownership or voting partnership interests of which is
sufficient to elect at least a majority of its Board of Directors
or other governing body, or, if there are no such voting interests,
50% or more of the equity interests of which is owned directly or
indirectly by, such first Person.
“
Trading Day ” means (a) a day on which the Common
Stock is traded on the OTC Bulletin Board, or (b) if the
Common Stock is then traded on a registered national stock
exchange, a day on which the Common Stock is traded on such
registered national stock exchange, or (c) if the Common Stock
is not traded on the OTC Bulletin Board or a registered national
stock exchange, a day on which the Common Stock is quoted in the
over-the-counter market as reported by the National Quotation
Bureau Incorporated (or any similar organization or agency
succeeding its functions of reporting prices); provided ,
however , that in the event that the Common Stock is not
listed or quoted as set forth in (a), (b) or (c) hereof,
then Trading Day shall mean any day except Saturday, Sunday and any
day which is a federal legal holiday in the United States or any
day on which banking institutions in the State of New York are
authorized or required by law or other governmental action to
close.
“
Transaction Documents ” means this Agreement, the
Warrants and the Registration Rights Agreement.
“
Warrant Shares ” means the shares of Common Stock
issuable upon the exercise of the Warrants.
“
1933 Act ” means the Securities Act of 1933, as
amended, or any successor statute, and the rules and regulations
promulgated thereunder.
“
1934 Act ” means the Securities Exchange Act of 1934,
as amended, or any successor statute, and the rules and regulations
promulgated thereunder.
3
2.
Purchase and Sale of the Shares and Warrants . Subject to
the terms and conditions of this Agreement, on the Closing Date,
each of the Investors shall severally, and not jointly, purchase,
and the Company shall sell and issue to the Investors, the Shares
and Warrants in the respective amounts set forth opposite the
Investors’ names on the signature pages attached hereto in
exchange for their respective portion of the Purchase Price as
specified in Section 3 below. The Investors acknowledge that
the Investors are purchasing the Securities pursuant to a private
placement of up to twenty million (20,000,000) Units of the Company
(the “Offering”) which shall terminate no later than
30 days from the date hereof. Each Unit consists of one share
of Common Stock and one-half (1/2) of one warrant to purchase
Common Stock, with each whole warrant entitling the holder to
purchase one share of Common Stock, exercisable for a period of two
years at a minimum of $0.40 per share and a maximum of $0.45 per
share, with the exercise price set between the minimum and maximum
at $0.03 above the closing price of the Company’s Common
Stock on the day immediately preceding to the execution of this
Agreement by the first Investor. In connection with the Offering,
the Investors acknowledge that there will be other Accredited
Investors reasonably satisfactory to the Investors who will be
purchasing such Units under terms no more favorable to the other
investors than the terms of this Agreement and the Transaction
Documents (the “Other Investment”), and other
individuals who will receive warrants for services rendered in
connection with the Offering. The investors in the Other Investment
and such individuals are hereinafter collectively referred to as
the “Other Investors”.
3.
Closing . Upon confirmation that the other conditions to
closing specified herein have been satisfied or duly waived by the
Investors, the Company shall deliver to Bullivant Houser Bailey PC
as escrow agent (“Escrow Agent”), pursuant to the terms
of that certain Escrow Agreement, attached hereto as
Exhibit B , and incorporated herein by reference
(“Escrow Agreement”), a certificate or certificates,
registered in such name or names as the Investors may designate,
representing the Shares and Warrants, with instructions that such
certificates are to be held for release to the Investors only upon
payment in full of the Purchase Price to the Company by all the
Investors. Upon confirmation that the other conditions to closing
specified herein have been satisfied or duly waived by the Company,
each Investor shall promptly cause a wire transfer in same day
funds to be sent to Escrow Agent pursuant to the terms of the
Escrow Agreement, in an amount representing such Investor’s
pro rata portion of the Purchase Price as set forth on the
signature pages to this Agreement. On the date (the “Closing
Date”) the Escrow Agent receives the Purchase Price and the
certificates evidencing the Shares and Warrants, and receives
written instructions from both the Company and the holders of a
majority of the Shares and Warrants, the Purchase Price and the
certificates evidencing the Shares and Warrants shall be released
from the escrow in accordance with the Escrow Agreement (the
“Closing”). The Closing of the purchase and sale of the
Shares and Warrants shall take place at the offices of Bullivant
Houser Bailey, PC, 1415 L Street, 10th Floor, Sacramento,
California, 95814, or at such other location and on such other date
as the Company and the Investors shall mutually agree.
4.
Representations and Warranties of the Company . The Company
hereby represents and warrants to the Investors:
4.1
Organization, Good Standing and Qualification . The Company
and each Subsidiary is an entity duly incorporated or otherwise
duly organized, validly existing and in
4
good standing
under the laws of the jurisdiction of its incorporation or
organization and has all requisite power and authority to carry on
its business as now conducted and to own and use its properties.
Each of the Company and its Subsidiaries is duly qualified to do
business as a foreign corporation and is in good standing in each
jurisdiction in which the conduct of its business or its ownership
or leasing of property makes such qualification or leasing
necessary unless the failure to so qualify has not and could not
reasonably be expected to have a Material Adverse Effect and no
proceeding has been instituted in any such jurisdiction revoking,
limiting or curtailing or seeking to revoke, limit or curtail such
power and authority or qualification. The Company’s
Subsidiaries are listed on Schedule 4.1
hereto.
4.2
Authorization . The Company has full corporate power and
authority and has taken all requisite corporate action on the part
of the Company, its officers, directors and stockholders necessary
for (i) the authorization, execution and delivery of the
Transaction Documents, (ii) the authorization of the
performance of all obligations of the Company hereunder or
thereunder, and (iii) the authorization, issuance (or
reservation for issuance) and delivery of the Securities. The
Transaction Documents constitute the legal, valid and binding
obligations of the Company, enforceable against the Company in
accordance with their terms, subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of
general applicability, relating to or affecting creditors’
rights generally.
4.3
Capitalization . Schedule 4.3 sets forth
(a) the authorized capital stock of the Company on the date
hereof; (b) the number of shares of capital stock issued and
outstanding; (c) the number of shares of capital stock
issuable pursuant to the Company’s stock plans; and
(d) the number of shares of capital stock issuable and
reserved for issuance pursuant to securities (other than the Shares
and the Warrants) exercisable for, or convertible into or
exchangeable for any shares of capital stock of the Company. All of
the issued and outstanding shares of the Company’s capital
stock have been duly authorized and validly issued and are fully
paid, nonassessable and free of pre-emptive rights and were issued
in full compliance with applicable state and federal securities law
and any rights of third parties. Except as described on
Schedule 4.3 , all of the issued and outstanding shares
of capital stock of each Subsidiary have been duly authorized and
validly issued and are fully paid, nonassessable and free of
pre-emptive rights, were issued in full compliance with applicable
state and federal securities law and any rights of third parties
and are owned by the Company, beneficially and of record, subject
to no lien, encumbrance or other adverse claim. Except as described
on Schedule 4.3 , no Person is entitled to pre-emptive or
similar statutory or contractual rights with respect to any
securities of the Company. Except as described on
Schedule 4.3 , there are no outstanding warrants,
options, convertible securities or other rights, agreements or
arrangements of any character under which the Company or any of its
Subsidiaries is or may be obligated to issue any equity securities
of any kind and except as contemplated by this Agreement, neither
the Company nor any of its Subsidiaries is currently in
negotiations for the issuance of any equity securities of any kind.
Except as described on Schedule 4.3 and except for the
Registration Rights Agreement, there are no voting agreements,
buy-sell agreements, option or right of first purchase agreements
or other agreements of any kind among the Company and any of the
security holders of the Company relating to the securities of the
Company held by them. Except as described on
Schedule 4.3 and except as provided in the Registration
Rights Agreement, no Person has the right to require the Company to
register any securities of the Company under the 1933 Act, whether
on a demand
5
basis or in
connection with the registration of securities of the Company for
its own account or for the account of any other Person.
Except
as described on Schedule 4.3 , the issuance and sale of
the Securities hereunder will not obligate the Company to issue
shares of Common Stock or other securities to any other Person
(other than the Investors) and will not result in the adjustment of
the exercise, conversion, exchange or reset price of any
outstanding security.
Except
as described on Schedule 4.3 , the Company does not
have outstanding stockholder purchase rights or “poison
pill” or any similar arrangement in effect giving any Person
the right to purchase any equity interest in the Company upon the
occurrence of certain events.
4.4
Valid Issuance . The Shares have been duly and validly
authorized and, when issued and paid for pursuant to this
Agreement, will be validly issued, fully paid and nonassessable,
and shall be free and clear of all encumbrances and restrictions
(other than those created by the Investors), except for
restrictions on transfer set forth in the Transaction Documents or
imposed by applicable securities laws. The Warrants have been duly
and validly authorized. Upon the due exercise of the Warrants, the
Warrant Shares will be validly issued, fully paid and
non-assessable free and clear of all encumbrances and restrictions,
except for restrictions on transfer set forth in the Transaction
Documents or imposed by applicable securities laws and except for
those created by the Investors. The Company has reserved the
maximum number of shares of Common Stock issuable pursuant to this
Agreement and the Warrants.
4.5
Consents . The execution, delivery and performance by the
Company of the Transaction Documents and the offer, issuance and
sale of the Securities require no consent of, action by or in
respect of, or filing with, any Person, governmental body, agency,
or official other than filings that have been made pursuant to
applicable state securities laws and post-sale filings pursuant to
applicable state and federal securities laws which the Company
undertakes to file within the applicable time periods. Subject to
the accuracy of the representations and warranties of each Investor
set forth in Section 5 hereof, on or prior to the Closing the
Company will have taken all action necessary to exempt (i) the
issuance and sale of the Securities, (ii) the issuance of the
Warrant Shares upon due exercise of the Warrants, and
(iii) the other transactions contemplated by the Transaction
Documents from the provisions of any stockholder rights plan or
other “poison pill” arrangement, any anti-takeover,
business combination or control share law or statute binding on the
Company or to which the Company or any of its assets and properties
may be subject and any provision of the Company’s Articles of
Incorporation or By-laws that is or could reasonably be expected to
become applicable to the Investors as a result of the transactions
contemplated hereby, including without limitation, the issuance of
the Securities and the ownership, disposition or voting of the
Securities by the Investors or the exercise of any right granted to
the Investors pursuant to this Agreement or the other Transaction
Documents.
4.6
Delivery of SEC Filings; Business . The Company has made
available to the Investors through the EDGAR system, true and
complete copies of the Company’s most recent Annual Report on
Form 10-KSB for the fiscal year ended December 31, 2006 (the
“10-KSB”),
6
and all other
reports filed by the Company pursuant to the 1934 Act since the
filing of the 10-KSB and prior to the date hereof (collectively,
the “SEC Filings”). The SEC Filings are the only
filings required of the Company pursuant to the 1934 Act for such
period. The Company and its Subsidiaries are engaged in all
material respects only in the business described in the SEC Filings
and the SEC Filings contain a complete and accurate description in
all material respects of the business of the Company and its
Subsidiaries, taken as a whole.
4.7
Use of Proceeds . The net proceeds of the sale of the Shares
and the Warrants comprising the Units hereunder shall be used by
the Company for working capital and general corporate
purposes.
4.8
No Material Adverse Change . Since December 31, 2006,
except as identified and described on Schedule 4.8 ,
there has not been:
(i) any
change in the consolidated assets, liabilities, financial condition
or operating results of the Company from that reflected in the
financial statements included in the Company’s 10-KSB, except
for changes in the ordinary course of business which have not had
and could not reasonably be expected to have a Material Adverse
Effect, individually or in the aggregate;
(ii) any
declaration or payment of any dividend, or any authorization or
payment of any distribution of cash or other property, on any of
the capital stock of the Company, or any purchase, redemption or
made any agreement to purchase or redeem or repurchase of any
securities of the Company;
(iii) any
material damage, destruction or loss, whether or not covered by
insurance to any assets or properties of the Company or its
Subsidiaries;
(iv) any
waiver, not in the ordinary course of business, by the Company or
any Subsidiary of a material right or of a material debt owed to
it;
(v) any
satisfaction or discharge of any lien, claim or encumbrance or
payment of any obligation by the Company or a Subsidiary, except in
the ordinary course of business and which is not material to the
assets, properties, financial condition, operating results or
business of the Company and its Subsidiaries taken as a whole (as
such business is presently conducted and as it is proposed to be
conducted); !
(vi) any
change or amendment to the Company’s Articles of
Incorporation or Bylaws, or material change to any material
contract or arrangement by which the Company or any Subsidiary is
bound or to which any of their respective assets or properties is
subject;
(vii) any
material labor difficulties or labor union organizing activities
with respect to employees of the Company or any
Subsidiary;
7
(viii) any
material transaction entered into by the Company or a Subsidiary
other than in the ordinary course of business;
(ix) the
loss of the services of any key employee, or material change in the
composition or duties of the senior management of the Company or
any Subsidiary;
(x) the
loss or threatened loss of any customer which has had or could
reasonably be expected to have a Material Adverse
Effect;
(xi) any
alteration of its method of accounting;
(xii) any
issuance of any securities to any officer, director or Affiliate,
except pursuant to existing Company stock option plans;
or
(xiii) any
other event or condition of any character that has had or could
reasonably be expected to have a Material Adverse
Effect.
4.9
SEC Filings . Except as disclosed on
Schedule 4.9 , since December 31, 2005 (the
“Reporting Period”), the Company has filed on a timely
basis all reports, schedules, forms, statements and other documents
required to be filed by it with the SEC pursuant to the reporting
requirements of the 1934 Act. As of their respective filing dates,
the SEC Filings complied in all material respects with the
requirements of the 1934 Act applicable to the SEC Filings, and
none of the SEC Filings, at the time they were filed with the SEC,
contained any untrue statement of a material fact or omitted to
state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. As of
their respective filing dates, the financial statements of the
Company included in the SEC Filings complied as to form in all
material respects with applicable accounting requirements and the
published rules and regulations of the SEC with respect thereto.
Such financial statements have been prepared in accordance with
United States generally accepted accounting principles,
consistently applied, during the periods involved (except
(i) as may be otherwise indicated in such financial statements
or the notes thereto, or (ii) in the case of unaudited interim
statements, to the extent they may exclude footnotes or may be
condensed or summary statements) and fairly present in all material
respects the financial position of the Company as of the dates
thereof and the results of its operations and cash flows for the
periods then ended (subject, in the case of unaudited statements,
to normal year-end audit adjustments).
4.10
No Conflict, Breach, Violation or Default . The execution,
delivery and performance of the Transaction Documents by the
Company and the issuance and sale of the Securities and the
consummation by the Company of the transactions contemplated herein
will not (i) conflict with or result in a breach or violation
of any of the terms and provisions of the Company’s Articles
of Incorporation, the Company’s Bylaws, both as in effect on
the date hereof (true and complete copies of which have been made
available to the Investors through the EDGAR system), or any
Subsidiary’s certificate or articles of incorporation, bylaws
or other organizational or charter documents (each as in effect of
the date hereof), or (ii) conflict with or result in a
violation of any statute, rule, regulation or order of any
governmental agency or body
8
or any court,
domestic or foreign, having jurisdiction over the Company, any
Subsidiary or any of their respective assets or properties, or
(iii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under,
result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or, to the knowledge of
the Company, give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time
or both) of, any agreement, credit facility, debt or other
instrument (evidencing a Company or Subsidiary debt or otherwise)
or other understanding to which the Company or any Subsidiary is a
party or by which any property or asset of the Company or any
Subsidiary is bound or affected.
4.11
Tax Matters . Except as described on
Schedule 4.11 , the Company and each Subsidiary has
timely prepared and filed all tax returns required to have been
filed by the Company or such Subsidiary and timely paid all taxes
shown thereon or otherwise owed by it. The charges, accruals and
reserves on the books of the Company in respect of taxes for all
fiscal periods are adequate in all material respects, and there are
no material unpaid assessments against the Company or any
Subsidiary nor, to the Company’s Knowledge, any basis for the
assessment of any additional taxes, penalties or interest for any
fiscal period or audits by any federal, state or local taxing
authority except for any assessment which is not material to the
Company and its Subsidiaries, taken as a whole. All taxes and other
assessments and levies that the Company or any Subsidiary is
required to withhold or to collect for payment have been duly
withheld and collected and paid to the proper governmental entity
or third party when due. There are no tax liens or claims pending
or, to the Company’s Knowledge, threatened against the
Company or any Subsidiary or any of their respective assets or
property. Except as described on Schedule 4.11 , there
are no outstanding tax sharing agreements or other such
arrangements between the Company and any Subsidiary or other
corporation or entity.
4.12
Title to Properties . Except as described on
Schedule 4.12 , to the Company’s knowledge, the
Company and each Subsidiary has good and marketable title to all
real properties and all other properties and assets owned by it, in
each case free from liens, encumbrances and defects that would
materially affect the value thereof or materially interfere with
the use made or currently planned to be made thereof by them; and
except as disclosed on Schedule 4.12, the Company and each
Subsidiary holds any leased real or personal property under valid
and enforceable leases with no exceptions that would materially
interfere with the use made or currently planned to be made thereof
by them.
4.13
Certificates, Authorities and Permits . Except as described
in Schedule 4.13 , the Company and each Subsidiary possess
adequate certificates, authorizations and permits issued by
appropriate federal, state, local or foreign regulatory agencies or
bodies necessary to conduct their respective businesses, and
neither the Company nor any Subsidiary has received any notice of
proceedings relating to the revocation or modification of any such
certificate, authorization or permit.
(a) Except
as set forth on Schedule 4.14 , the Company is not a
party to or bound by any collective bargaining agreements or other
agreements with labor organizations.
9
The Company has
not violated in any material respect any laws, regulations, orders
or contract terms, affecting the collective bargaining rights of
employees, labor organizations or any laws, regulations or orders
affecting employment discrimination, equal opportunity employment,
or employees’ health, safety, welfare, wages and
hours.
(b) (i) There
are no labor disputes existing, or to the Company’s
Knowledge, threatened, involving strikes, slow-downs, work
stoppages, job actions, disputes, lockouts or any other disruptions
of or by the Company’s employees, (ii) there are no
unfair labor practices or petitions for election pending or, to the
Company’s Knowledge, threatened before the National Labor
Relations Board or any other federal, state or local labor
commission relating to the Company’s employees, (iii) no
demand for recognition or certification heretofore made by any
labor organization or group of employees is pending with respect to
the Company and (iv) to the Company’s Knowledge, the
Company enjoys good labor and employee relations with its employees
and labor organizations.
(c) The
Company is, and at all times has been, in compliance in all
material respects with all applicable laws respecting employment
(including laws relating to classification of employees and
independent contractors) and employment practices, terms and
conditions of employment, wages and hours, and immigration and
naturalization. There no claims are pending against the Company
before the Equal Employment Opportunity Commission or any other
administrative body or in any court asserting any violation of
Title VII of the Civil Rights Act of 1964, the Age Discrimination
Act of 1967, 42 U.S.C. §§ 1981 or 1983 or any other
federal, state or local Law, statute or ordinance barring
discrimination in employment.
(d) Except
as described on Schedule 4.14 , the Company is not a
party to, or bound by, any employment or other contract or
agreement that contains any severance, termination pay or change of
control liability or obligation, including, without limitation, any
“excess parachute payment,” as defined in Section
2806(b) of the Internal Revenue Code.
(e) Except
as specified in Schedule 4.14 , each of the
Company’s employees who works in the United States is a
Person who is either a United States citizen or a permanent
resident entitled to work in the United States. To the
Company’s Knowledge, the Company has no liability for the
improper classification by the Company of such employees as
independent contractors or leased employees prior to the
Closing.
4.15
Intellectual Property .
(a) All
Intellectual Property of the Company and its Subsidiaries is
currently in compliance with all legal requirements (including
timely filings, proofs and payments of fees) and is valid and
enforceable. No Intellectual Property of the Company or its
Subsidiaries which is necessary for the conduct of Company’s
and each of its Subsidiaries’ respective businesses as
currently conducted or as currently proposed to be conducted has
been or is now involved in any cancellation, dispute or litigation,
and, to the Company’s Knowledge, no such action is
threatened. No patent of the Company or its Subsidiaries has been
or is now involved in any interference, reissue, re-examination or
opposition proceeding.
10
(b) The
Company and its Subsidiaries own or have the valid right to use all
of the Intellectual Property that is necessary for the conduct of
the Company’s and each of its Subsidiaries’ respective
businesses as currently conducted or as currently proposed to be
conducted and for the ownership, maintenance and operation of the
Company’s and its Subsidiaries’ properties and assets,
free and clear of all liens, encumbrances, adverse claims or
obligations to license all such owned Intellectual Property and
Confidential Information, other than licenses entered into in the
ordinary course of the Company’s and its Subsidiaries’
businesses. The Company and its Subsidiaries have a valid and
enforceable right to use all third party Intellectual Property and
Confidential Information used or held for use in the respective
businesses of the Company and its Subsidiaries.
(c) The
conduct of the Company’s and its Subsidiaries’
businesses as currently conducted does not infringe or otherwise
impair or conflict with (collectively, “Infringe”) any
Intellectual Property rights of any third party or any
confidentiality obligation owed to a third party, and, to the
Company’s Knowledge, the Intellectual Property and
Confidential Information of the Company and its Subsidiaries which
are necessary for the conduct of Company’s and each of its
Subsidiaries’ respective businesses as currently conducted or
as currently proposed to be conducted are not being Infringed by
any third party. There is no litigation or order pending or
outstanding or, to the Company’s Knowledge, threatened or
imminent, that seeks to limit or challenge or that concerns the
ownership, use, validity or enforceability of any Intellectual
Property or Confidential Information of the Company and its
Subsidiaries and the Company’s and its Subsidiaries’
use of any Intellectual Property or Confidential Information owned
by a third party, and, to the Company’s Knowledge, there is
no valid basis for the same.
(a) the
Company and the Subsidiaries, taken as a whole, owns, controls or
has legal rights to, through mining tenements of various types and
descriptions, all of the rights, titles and interests materially
necessary or appropriate to authorize and enable it to carry on the
material mineral exploration and/or mining activities as currently
being undertaken and has obtained or, upon performance of all
conditions precedent will be able to obtain such rights, titles and
interests as may be required to implement its plans on its
properties and the Subsidiaries taken as a whole and is not in
material default of such rights, titles and interests;
(b) all
assessments or other work required to be performed in relation to
the material mining claims and the mining rights of the Company in
order to maintain the Company’s interest therein, if any,
have been performed to date and the Company and the Subsidiaries
have complied in all material respects with all applicable
governmental laws, regulations and policies in this connection as
well as with regard to legal, contractual obligations to third
parties in this connection except in respect of mining claims and
mining rights that the Company or any of the Subsidiaries intends
to abandon or relinquish and except for any non-compliance which
would not either individually or in the aggregate have a Material
Adverse Effect. All such mining claims and mining rights are in
good standing in all material respects as of the date of this
agreement;
11
(c) to
the Company’s knowledge, all mining operations on the
properties of the Company and the Subsidiaries have been conducted
in all material respects in accordance with good mining and
engineering practices and all applicable workers’
compensation and health and safety and workplace laws, regulations
and policies have been duly complied with in all material respects;
and
(d) there
are no environmental audits, evaluations, assessments, studies or
tests relating to the Company or any of its Subsidiaries except for
ongoing assessments conducted by or on behalf of the Company in the
ordinary course.
4.17
Environmental Matters . To the Company’s Knowledge,
neither the Company nor any Subsidiary is in violation of any
statute, rule, regulation, decision or order of any governmental
agency or body or any court, domestic or foreign, relating to the
use, disposal or release of hazardous or toxic substances or
relating to the protection or restoration of the environment or
human exposure to hazardous or toxic substances (collectively,
“Environmental Laws”), owns or operates any real
property contaminated with any substance that is subject to any
Environmental Laws, is liable for any off-site disposal or
contamination pursuant to any Environmental Laws, or is subject to
any claim relating to any Environmental Laws, which violation,
contamination, liability or claim has had or could reasonably be
expected to have a Material Adverse Effect, individually or in the
aggregate; and there is no pending or, to the Company’s
Knowledge, threatened investigation that might lead to such a
claim.
4.18
Litigation . Except as described on
Schedule 4.18 , there is no action, suit, inquiry,
notice of violation, proceeding or investigation pending or, to the
Company’s Knowledge, threatened against or affecting the
Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative
agency or regulatory authority (federal, state, county, local or
foreign) (collectively, an “ Action ”). Neither
the Company nor any Subsidiary, nor any director or officer
thereof, is or has been the subject of any Action involving a claim
of violation of or liability under United States federal or state
securities laws or a claim of breach of fiduciary duty. There has
not been, and to the Company’s Knowledge, there is not
pending or contemplated, any investigation by the SEC involving the
Company or any current or former director or officer of the
Company. The SEC has not issued any stop order or other order
suspending the effectiveness of any document or registration
statement filed by the Company or any Subsidiary under the 1933
Act.
4.19
Insurance Coverage . The Company and each Subsidiary
maintains in full force and effect insurance coverage that is
prudent and customary for comparably situated companies for the
business being conducted and properties owned or leased by the
Company and each Subsidiary, and the Company reasonably believes
such insurance coverage to be adequate against all liabilities,
claims and risks against which it is customary for comparably
situated companies to insure. Neither the Company nor any
Subsidiary has any reason to believe that it will not be able to
renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may
be necessary to continue its respective business without a
significant increase in cost.
12
4.20
Brokers and Finders . No Person will have, as a result of
the transactions contemplated by the Transaction Documents, any
valid right, interest or claim against or upon the Company, any
Subsidiary or an Investor for any commission, fee or other
compensation pursuant to any agreement, arrangement or
understanding entered into by or on behalf of the Company, other
than as described in Schedule 4.20 . Any such
commission, fee or other compensation listed on
Schedule 4.20 paid by the Company shall comply with
applicable United States federal and state broker-dealer laws. The
Investors shall have no obligation with respect to any fees or with
respect to any claims made by or on behalf of other Persons for
fees of a type contemplated in this Section (other than for Persons
engaged by any Investor or its investment advisor) that may be due
in connection with the transactions contemplated by the Transaction
Documents.
4.21
No General Solicitation or General Advertising . Neither the
Company nor any Person acting on its behalf has offered or sold or
will offer or sell any of the Units by any form of “general
solicitation” or “general advertising” (as those
terms are used in Regulation D) in connection with the offer
or sale of any of the Units. The Company has offered the Units for
sale only to the Investors and certain other “accredited
investors” within the meaning of Rule 501(a) under
Regulation D.
4.22
No Integrated Offering . Neither the Company nor any of its
Affiliates, nor any Person acting on its or their behalf has,
directly or indirectly, made any offers or sales of any Company
security or solicited any offers to buy any security, under
circumstances that would cause this offering of the Units to be
integrated with prior offerings by the Company within the last six
months for purposes of the 1933 Act which would require
registration of the Securities under the 1933 Act.
4.23
Private Placement . The offer and sale of the Securities to
the Investors as contemplated hereby is exempt from the
registration requirements of the 1933 Act pursuant to Rule 506 of
Regulation D.
4.24
Foreign Corrupt Practices . Neither the
Company nor any of its Subsidiaries nor, to the Company’s
Knowledge, any of their respective current or former stockholders,
directors, officers, employees, agents or other Persons acting on
behalf of the Company or any Subsidiary, has on behalf of the
Company or any Subsidiary or in connection with their respective
businesses: (a) directly or indirectly used any corporate funds for
unlawful contributions, gifts, entertainment or other unlawful
expenses relating to political activity; (b) made any direct
or indirect unlawful payments to any governmental officials or
employees from corporate funds; (c) established or maintained
any unlawful or unrecorded fund of corporate monies or other
assets; (d) made any false or fictitious entries on the books
and records of the Company or any Subsidiary; (e) made any
unlawful bribe, rebate, payoff, influence payment, kickback or
other unlawful payment of any nature; or (f) violated in any
material respect any provision of the Foreign Corrupt Practices Act
of 1977, as amended.
4.25
Transactions with Affiliates . Except as disclosed on
Schedule 4.25 , none of the officers or directors of
the Company and, to the Company’s Knowledge, none of the
employees of the Company is presently a party to any transaction
with the Company or any
13
Subsidiary
(other than as holders of stock options and/or warrants, and for
services as employees, officers and directors), including any
contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or
personal property to or from, or otherwise requiring payments to or
from any officer, director or such employee or, to the
Company’s Knowledge, any entity in which any officer,
director, or any such employee has a substantial interest or is an
officer, director, trustee or partner.
4.26
Internal Controls . Except as described in
Schedule 4.26 , the Company is in material compliance
with the provisions of the Sarbanes-Oxley Act of 2002 currently
applicable to the Company as of the Closing Date. The Company and
the Subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with
management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with U.S. GAAP
and to maintain asset accountability, (iii) access to assets
is permitted only in accordance with management’s general or
specific authorization, and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any
differences. The Company has established disclosure controls and
procedures (as defined in 1934 Act Rules 13a-14 and 15d-14)
for the Company and designed such disclosure controls and
procedures to ensure that material information relating to the
Company, including the Subsidiaries, is made known to the
certifying officers by others within those entities, particularly
during the period in which the Company’s most recently filed
period report under the 1934 Act, as the case may be, is being
prepared. The Company’s certifying officers have evaluated
the effectiveness of the Company’s controls and procedures as
of the end of the period covered by the most recently filed
periodic report under the 1934 Act (such date, the
“Evaluation Date”). The Company presented in its most
recently filed periodic report under the 1934 Act the conclusions
of the certifying officers about the effectiveness of the
disclosure controls and procedures based on their evaluations as of
the Evaluation Date. Since the Evaluation Date, there have been no
significant changes in the Company’s internal controls (as
such term is defined in Item 308 of Regulation S-K) or,
to the Company’s Knowledge, in other factors that could
significantly affect the Company’s internal controls. The
Company maintains and will continue to maintain a standard system
of accounting established and administered in accordance with GAAP
and the applicable requirements of the 1934 Act.
4.27
Disclosures . Neither the Company nor any Person acting on
its behalf has provided the Investors or their agents or counsel
with any information that constitutes or might constitute material,
non-public information. The Company understands and confirms that
the Investors will rely on the foregoing representation in
effecting transactions in securities of the Company. All disclosure
furnished by or on behalf of the Company to the Investors regarding
the Company, its business and the transactions contemplated hereby,
including the schedules to this Agreement are true and correct, and
does not contain any untrue statements of a material fact or omit
to state a material fact necessary in order to make the statements
contained therein, in light of the circumstances under which they
were made, not misleading.
4.28.
Investment Company . The Company is not, and is not an
Affiliate of, and immediately after receipt of payment for the
Units, will not be or be an Affiliate of, an
14
“investment company” within the
meaning of the Investment Company Act of 1940, as amended. The
Company shall conduct its business in a manner so that it will not
become subject to the Investment Company Act of 1940, as
amended.
4.29.
Registration Rights . Except as disclosed on
Schedule 4.29 , other than each of the Investors, no
Person has any right to cause the Company to effect the
registration under the 1933 Act of any securities of the
Company.
4.30.
No Disagreements with Accountants and Lawyers . There are no
disagreements of any kind presently existing, or reasonably
anticipated by the Company to arise, between the Company and the
accountants and lawyers formerly or presently employed by the
Company which could affect the Company’s ability to perform
any of its obligations under any of the Transaction Documents, and
the Company is current with respect to any fees owed to its
accountants and lawyers.
4.31.
Acknowledgement Regarding Investor’s Trading Activity
. It is understood and acknowledged by the Company (i) that
none of the Investors have been asked by the Company or its
Subsidiaries to agree, nor has any Investor agreed with the Company
or its Subsidiaries, to desist from purchasing or selling, long
and/or short, securities of the Company, or
“derivative” securities based on securities issued by
the Company or to hold the Securities for any specified term;
(ii) that past or future open market or other transactions by
any Investor, including, without limitation, short sales or
“derivative” transactions, before or after the closing
of this or future private placement transactions, may negatively
impact the market price of the Company’s publicly-traded
securities; (iii) that any Investor, and counter parties in
“derivative” transactions to which any such Investor is
a party, directly or indirectly, presently may have a
“short” position in the Common Stock, and
(iv) that each Investor shall not be deemed to have any
affiliation with or control over any arm’s length
counter-party in any “derivative” transaction. The
Company further understands and acknowledges that (a) one or
more Investors may engage in hedging and/or trading activities at
various times during the period that the Securities are
outstanding, and (b) such hedging and/or trading activities
(if any) could reduce the value of the existing stockholders’
equity interests in the Company at and after the time that the
hedging and/or trading activities are being conducted.
4.32.
Regulation M Compliance . The Company has not, and to
the Company’s Knowledge no one acting on its behalf has,
(i) taken, directly or indirectly, any action designed to
cause or to result in the stabilization or manipulation of the
price of any security of the Company to facilitate the sale or
resale of any of the Securities, (ii) sold, bid for,
purchased, or, paid any compensation for soliciting purchases of,
any of the Securities, or (iii) paid or agreed to pay to any
Person any compensation for soliciting another to purchase any
other securities of the Company.
4.33.
Form SB-2 Eligibility . The Company is eligible to
register the resale of the Securities for resale by the Investors
on Form SB-2 promulgated under the 1933 Act.
5.
Representations and Warranties of the Investors . Each of
the Investors hereby severally, and not jointly, represents and
warrants to the Company that:
15
5.1
Organization and Existence . Such Investor is a validly
existing corporation, limited partnership or limited liability
company and in good standing under the laws of the jurisdiction of
its organization, and has all requisite corporate, partnership or
limited liability company power and authority to enter into and to
consummate the transactions contemplated by the Transaction
Documents and otherwise carry out its obligations
thereunder.
5.2
Authorization . The execution, delivery and performance by
such Investor of the Transaction Documents to which such Investor
is a party have been duly authorized by all requisite corporate,
partnership or limited liability company action, and will each
constitute the valid and legally binding obligation of such
Investor, enforceable against such Investor in accordance with
their respective terms, subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of
general applicability, relating to or affecting creditors’
rights generally.
5.3
Purchase Entirely for Own Account . The Securities to be
received by such Investor hereunder will be acquired for such
Investor’s own account, not as nominee or agent, and not with
a view to the resale or distribution of any part thereof in
violation of the 1933 Act, and such Investor has no present
intention of selling, granting any participation in, or otherwise
distributing the same in violation of the 1933 Act without
prejudice, however, to such Investor’s right at all times to
sell or otherwise dispose of all or any part of such Securities in
compliance with applicable federal and state securities laws
. Nothing contained herein shall be deemed a representation
or warranty by such Investor to hold the Securities for any minimum
or other specific term nor limiting such Investor’s right to
sell the Securities at any time pursuant to the Registration
Statement or otherwise in compliance with applicable federal and
state securities laws. Such Investor is not a broker-dealer
registered with the SEC under the 1934 Act or an entity engaged in
a business that would require it to be so registered.
5.4
Investor Status . At the time such Investor was offered the
Units, it was, and at the date hereof it is, and on each date on
which it exercises any Warrants, it will be an “accredited
investor” as defined in Rule 501(a) under the 1933 Act. Such
Investor is not required to be registered as a broker-dealer under
Section 15 of the 1934 Act. Each Investor represents that, to
the extent that it is an organizational entity, it has been
organized under the laws of the state or country set forth opposite
its name on the signature pages hereto.
5.5
Experience of Such Investor . Such Investor, either alone or
together with its representatives, has such knowledge,
sophistication and experience in business and financial matters so
as to be capable of evaluating the merits and risks of the
prospective investment in the Units, and has so evaluated the
merits and risks of such investment. Such Invest
|